全文获取类型
收费全文 | 27301篇 |
免费 | 2235篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 351篇 |
儿科学 | 838篇 |
妇产科学 | 656篇 |
基础医学 | 3887篇 |
口腔科学 | 580篇 |
临床医学 | 2847篇 |
内科学 | 5619篇 |
皮肤病学 | 341篇 |
神经病学 | 2108篇 |
特种医学 | 932篇 |
外国民族医学 | 1篇 |
外科学 | 4116篇 |
综合类 | 264篇 |
一般理论 | 21篇 |
预防医学 | 2302篇 |
眼科学 | 1161篇 |
药学 | 1797篇 |
中国医学 | 23篇 |
肿瘤学 | 1758篇 |
出版年
2023年 | 137篇 |
2021年 | 447篇 |
2020年 | 352篇 |
2019年 | 474篇 |
2018年 | 600篇 |
2017年 | 504篇 |
2016年 | 542篇 |
2015年 | 616篇 |
2014年 | 840篇 |
2013年 | 1161篇 |
2012年 | 1633篇 |
2011年 | 1648篇 |
2010年 | 940篇 |
2009年 | 853篇 |
2008年 | 1445篇 |
2007年 | 1483篇 |
2006年 | 1450篇 |
2005年 | 1412篇 |
2004年 | 1438篇 |
2003年 | 1269篇 |
2002年 | 1228篇 |
2001年 | 546篇 |
2000年 | 555篇 |
1999年 | 544篇 |
1998年 | 300篇 |
1997年 | 236篇 |
1996年 | 222篇 |
1995年 | 245篇 |
1994年 | 240篇 |
1993年 | 216篇 |
1992年 | 388篇 |
1991年 | 400篇 |
1990年 | 402篇 |
1989年 | 404篇 |
1988年 | 324篇 |
1987年 | 346篇 |
1986年 | 292篇 |
1985年 | 364篇 |
1984年 | 283篇 |
1983年 | 233篇 |
1982年 | 210篇 |
1981年 | 201篇 |
1980年 | 173篇 |
1979年 | 216篇 |
1978年 | 169篇 |
1977年 | 137篇 |
1976年 | 117篇 |
1975年 | 124篇 |
1974年 | 143篇 |
1973年 | 124篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Li Dong Mari Nygård Nathalie C. Støer Ole Klungsøyr Bo T. Hansen 《International journal of cancer. Journal international du cancer》2023,153(2):399-406
Human papillomavirus (HPV) vaccine effectiveness may differ between settings. Here we present the first real-world effectiveness study of HPV vaccination on high-grade cervical lesions from Norway, among women who received HPV vaccine outside the routine program. We performed an observational study of all Norwegian women born 1975 to 1996 and retrieved individual data from nationwide registries on HPV vaccination status and incidence of histologically verified high-grade cervical neoplasia during 2006 to 2016. We estimated the incidence rate ratio (IRR) and 95% confidence intervals (CI) for vaccination vs no vaccination by Poisson regression stratified by age at vaccination <20 years and ≥20 years. The cohort consisted of 832 732 women, of which 46 381 (5.6%) received at least one dose of HPV vaccine by the end of 2016. The incidence rate of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) increased with age regardless of vaccination status and was highest at age 25 to 29, at 637/100 000 among unvaccinated women, 487/100 000 among women vaccinated before age 20 and 831/100 000 among women vaccinated at age 20 or older. The adjusted IRR of CIN2+ between vaccinated and unvaccinated women was 0.62 (95% CI: 0.46-0.84) for women vaccinated below age 20, and 1.22 (95% CI: 1.03-1.43) for women vaccinated at age 20 or older. These findings indicate that HPV vaccination among women too old to be eligible for routine HPV vaccination is effective among women who are vaccinated below age 20 but may not have the desired impact among women who are vaccinated at age 20 or older. 相似文献
2.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
3.
Ramy Abdelmaseih Anamarys Blanco Randa Abdelmasih Krutika Desai Joshua Pothen Jay Patel Rama Balaraman 《Current problems in cardiology》2021,46(8):100854
Capecitabine has been more recognized for its cardiotoxicity with an incidence that varies widely. It demonstrates its toxicity in the forms of acute coronary syndrome, arrhythmias and, to a lesser extent, cardiomyopathy. There are several proposed theories including coronary vasospasm, endothelial injury, and oxidative stress. We present a case of capecitabine-induced cardiomyopathy in a patient with pancreatic cancer and mild coronary artery disease, and shed light on other cardio-toxic agents, their proposed mechanism of cardiotoxicity, and on cardiomyopathy in general. 相似文献
4.
5.
6.
7.
8.
Eric D. Hansen Mary M. Mitchell Dulce M. Cruz Oliver Fahid A. Alghanim Michelle Walter Amy A. Case Tom Smith Amy R. Knowlton 《Journal of pain and symptom management》2019,57(5):961-965
Context
In the era of effective antiretroviral therapy, persons living with HIV/AIDS (PLWHA) are living longer, transforming HIV from a universally fatal disease to a serious chronic illness, warranting discussions between patients and their loved ones about advance care planning (ACP). Evidence is needed on factors associated with patients' likelihood to discuss ACP with loved ones.Objectives
To further characterize factors associated with successful ACP in PLWHAs with their loved ones, we examined associations between patients having ACP discussions with the need for assistance with personal care, chronic pain, life satisfaction, prior family disagreements over health care decisions, sex, age, and interference in daily routines due to memory problems.Methods
Data were from the Affirm Care study (N = 370), which examined social and environmental factors associated with health outcomes among PLWHAs and their informal caregivers.Results
Slightly more than half of respondents discussed ACP with loved ones (57%). In adjusted analysis, higher levels of chronic pain (odds ratio [OR] = 2.09, P = 0.045), needing assistance with personal care (OR = 1.63, P = 0.023), greater life satisfaction (OR = 1.02, P = 0.002), prior family arguments over health care decisions (OR = 2.80, P < 0.001), and female sex (OR = 2.22, P = 0.001) were associated with higher odds of discussing ACP with loved ones, whereas age, drug use, education level, depression, and memory problems were nonsignificant.Conclusion
These results suggest that interventions to increase ACP among PLWHAs and their loved ones should target males. The findings also suggest PLWHAs with chronic pain, the need for assistance with personal care, and those with a history of prior family arguments over health care decisions may be primed for ACP. 相似文献9.
10.
Non‐melanoma skin cancer frequently results from chronic exposure to ultraviolet (UV) irradiation. UV‐induced DNA damage activates cell cycle arrest checkpoints through degradation of the cyclin‐dependent kinase activators, the cell division cycle 25 (CDC25) phosphatases. We previously reported increased CDC25A in nonmelanoma skin cancer, but CDC25B and CDC25C had not been previously examined. Consequently, we hypothesized that increased expression of CDC25B and CDC25C increases tumor cell proliferation and skin tumor growth. We found that CDC25B and CDC25C were increased in mouse and human skin cancers. CDC25B was primarily cytoplasmic in skin and skin tumors and was significantly increased in the squamous cell carcinoma (SCC), while CDC25C was mostly nuclear in the skin, with an increased cytoplasmic signal in the premalignant and malignant tumors. Surprisingly, forced expression of CDC25B or CDC25C in cultured SCC cells did not affect proliferation, but instead suppressed apoptosis, while CDC25C silencing increased apoptosis without impacting proliferation. Targeting CDC25C to the nucleus via mutation of its nuclear export sequence, however, increased proliferation in SCC cells. Overexpression of CDC25C in the nuclear compartment did not hinder the ability of CDC25C to suppress apoptosis, neither did mutation of sites necessary for its interaction with 14‐3‐3 proteins. Analysis of apoptotic signaling pathways revealed that CDC25C increased activating phosphorylation of Akt on Ser473, increased inhibitory phosphorylation of proapoptotic BAD on Ser136, and increased the survival protein Survivin. Silencing of CDC25C significantly reduced Survivin levels. Taken together, these data suggest that increased expression of CDC25B or CDC25C are mechanisms by which skin cancers evade apoptotic cell death. 相似文献